Hypertrophic osteoarthropathy associated with metastatic melanoma

被引:12
作者
Thompson, MA
Warner, NB
Hwu, WJ
机构
[1] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
[3] Univ Texas, Sch Med, Dept Internal Med, Div Rheumatol, Houston, TX 77030 USA
关键词
arthralgia; bisphosphonates; melanoma; neoplasm metastasis; paraneoplastic syndromes; secondary hypertrophic osteoarthropathy;
D O I
10.1097/00008390-200512000-00013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypertrophic osteoarthropathy (HOA) is one of the paraneoplastic syndromes most commonly associated with non-small-cell lung cancer. Although pulmonary metastasis is the second most common initial site of melanoma metastasis, HOA is rarely detected in patients with metastatic melanoma in the lung. We report a case of a 45-year-old woman with advanced melanoma who developed HOA after her disease had progressed through first-line systemic therapy. The patient's diagnosis of HOA was made on the basis of digital clubbing, arthralgia, pain, joint effusion and periosteal bone formation on X-ray with negative rheumatologic laboratory studies. Only six cases of HOA in metastatic melanoma have been reported previously. This diagnosis should be considered with lung metastases and the presentation of polyarthralgia with appropriate laboratory and imaging findings. Interestingly, the patient responded to bisphosphonates and second-line chemotherapy with carboplatin and paclitaxel, which is commonly used for lung cancer, not advanced melanoma. As with many paraneoplastic syndromes, successful treatment of the underlying disease was associated with a rapid resolution of the symptoms.
引用
收藏
页码:559 / 561
页数:3
相关论文
共 9 条
[1]   TREATMENT OF RESISTANT PAIN IN HYPERTROPHIC PULMONARY ARTHROPATHY WITH KETOROLAC [J].
BLACKWELL, N ;
BANGHAM, L ;
HUGHES, M ;
MELZACK, D ;
TROTMAN, I .
THORAX, 1993, 48 (04) :401-401
[2]  
BLUMENSAAT C, 1931, PROENTGENPRAXIS STUT, V3, P134
[3]  
Martinez-Lavin Manuel, 1997, Current Opinion in Rheumatology, V9, P83, DOI 10.1097/00002281-199701000-00016
[4]  
SETHI SM, 1974, CAN J SURG, V17, P221
[5]  
SILVERI F, 1992, CLIN EXP RHEUMATOL, V10, P61
[6]  
Sonoda T, 1975, J Tenn Med Assoc, V68, P716
[7]   Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma [J].
Suzuma, T ;
Sakurai, T ;
Yoshimura, G ;
Umemura, T ;
Tamaki, T ;
Yoshimasu, T ;
Naito, Y .
ANTI-CANCER DRUGS, 2001, 12 (09) :731-734
[8]  
WILSON KS, 1979, MAYO CLIN PROC, V54, P208
[9]   HYPERTROPHIC PULMONARY OSTEOARTHROPATHY IN ASSOCIATION WITH PULMONARY METASTASES FROM EXTRATHORACIC TUMOURS [J].
YACOUB, MH ;
SIMON, G ;
OHNSORGE, J .
THORAX, 1967, 22 (03) :226-&